Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011863) titled 'Early surgery or sodium glucose cotransporter-2 inhibitor add-on treatment in patients with severe tricuspid regurgitation' on April 16.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Samsung Medical Center
Condition:
Diseases of the circulatory system
Intervention:
Drug : Intervention group: Treatment of existing drugs + SGLT2 inhibitors (Dapagliflozin 10mg or Empagliflozin 10mg) Take PO once a day for one year
Control group: Traditional drug treatment
Recruitment Status: Recruiting
Phase:...